← Leaderboards
Edward Y Zamrini
University Of Alabama At Birmingham
$2,303,414
Attributed
$5,799,097
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,799,097 · 4
By mechanism
R01$2,789,671 · 1
RF1$2,328,377 · 1
P50$555,572 · 1
R41$125,477 · 1
Top collaborators
- Qing Zeng6 shared
- Ali Ahmed4 shared
- Peter F. Kokkinos2 shared
- Troy Andersen1 shared
- Norman L Foster1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Richard Mark Allman$7,670,574
- William E. Grizzle$27,727,915
- Catarina I Kiefe$24,282,131
- Page W Caufield$5,037,644
- Elizabeth Camille Vaughan$4,215,127
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAmericanDesignRecommendationVeteransArtificial IntelligenceS Disease Related DementiaPreventFamilyS DiseaseCostAfrican AmericanFutureFollow-UpDementiaElectronic Health RecordPreventionLinkSymptomsDeep LearningPublic HealthFitnessClinical DataInnovation
Grant awards (8)
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention$626,355
R01 · FY2025 · AG
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention$691,614
R01 · FY2024 · AG
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention$707,646
R01 · FY2023 · AG
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention$764,056
R01 · FY2022 · AG
Use Explainable AI to Improve the Trust of and Detect the Bias of AI Models$322,981
RF1 · FY2022 · AG
Physical Fitness as an Objective Biomarker for AD/ADRD Risk Modification$2,005,396
RF1 · FY2020 · AG
The Memory Care Navigator: A Proactive Guide$125,477
R41 · FY2012 · AG
CLINICAL CORE$555,572
P50 · FY2008 · AG · contact PI